Counterpoint Mutual Funds LLC Invests $288,000 in Avanos Medical, Inc. $AVNS

Key Points

• Counterpoint Mutual Funds LLC invested approximately $288,000 in Avanos Medical, acquiring 23,549 shares and representing about 0.05% of the company.
• Several institutional investors, including State of Wyoming and ProShare Advisors LLC, significantly increased their holdings in Avanos Medical, contributing to institutional investors owning 95.17% of the company's stock.
• Avanos Medical reported a loss of $0.01 per share last quarter, falling short of analysts' expectations, while the company set its fiscal year 2025 guidance at 0.750-0.950 EPS.

Counterpoint Mutual Funds LLC purchased a new position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 23,549 shares of the company's stock, valued at approximately $288,000. Counterpoint Mutual Funds LLC owned approximately 0.05% of Avanos Medical as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. State of Wyoming grew its position in Avanos Medical by 132.0% during the 4th quarter. State of Wyoming now owns 5,137 shares of the company's stock worth $82,000 after acquiring an additional 2,923 shares during the last quarter. Heritage Family Offices LLP bought a new stake in Avanos Medical during the 1st quarter worth $146,000. EntryPoint Capital LLC bought a new stake in Avanos Medical during the 1st quarter worth $181,000. ProShare Advisors LLC grew its position in Avanos Medical by 44.4% during the 4th quarter. ProShare Advisors LLC now owns 13,693 shares of the company's stock worth $218,000 after acquiring an additional 4,210 shares during the last quarter. Finally, EP Wealth Advisors LLC grew its position in Avanos Medical by 46.3% during the 1st quarter. EP Wealth Advisors LLC now owns 14,783 shares of the company's stock worth $212,000 after acquiring an additional 4,675 shares during the last quarter. Institutional investors and hedge funds own 95.17% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on AVNS. Zacks Research upgraded Avanos Medical to a "hold" rating in a research report on Tuesday, August 12th. Wall Street Zen lowered Avanos Medical from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 9th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of "Hold".

Avanos Medical Trading Up 1.0%

NYSE AVNS opened at $12.10 on Thursday. The business's 50-day moving average price is $11.65 and its two-hundred day moving average price is $12.42. Avanos Medical, Inc. has a 12 month low of $9.30 and a 12 month high of $24.23. The firm has a market capitalization of $561.46 million, a PE ratio of -1.20 and a beta of 1.12. The company has a current ratio of 2.64, a quick ratio of 1.58 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). Avanos Medical had a negative net margin of 66.89% and a positive return on equity of 6.16%. The company had revenue of $175.00 million during the quarter, compared to the consensus estimate of $165.50 million. During the same quarter last year, the firm posted $0.34 EPS. Avanos Medical has set its FY 2025 guidance at 0.750-0.950 EPS. On average, analysts expect that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Insider Activity at Avanos Medical

In related news, Director Gary Blackford purchased 40,000 shares of Avanos Medical stock in a transaction on Wednesday, August 13th. The shares were purchased at an average price of $10.99 per share, for a total transaction of $439,600.00. Following the transaction, the director owned 40,000 shares of the company's stock, valued at approximately $439,600. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 2.64% of the company's stock.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.